List of Excipients in API regadenoson
✉ Email this page to a colleague
Excipients in ANDA-approved (generic) drugs containing regadenoson
| Company | Ingredient | NDC | Excipient |
|---|---|---|---|
| Hospira Inc | regadenoson | 0409-1401 | EDETATE DISODIUM |
| Hospira Inc | regadenoson | 0409-1401 | PROPYLENE GLYCOL |
| Hospira Inc | regadenoson | 0409-1401 | SODIUM PHOSPHATE, DIBASIC, ANHYDROUS |
| Hospira Inc | regadenoson | 0409-1401 | SODIUM PHOSPHATE, MONOBASIC, MONOHYDRATE |
| >Company | >Ingredient | >NDC | >Excipient |
Detailed excipient profiles for regadenoson
Excipient focus: EDETATE DISODIUM
regadenoson drug variants containing EDETATE DISODIUM
| Company | Ingredient | NDC |
|---|---|---|
| Hospira Inc | regadenoson | 0409-1401 |
| Hikma Pharmaceuticals USA Inc | regadenoson | 0641-6253 |
| Baxter Healthcare Corporation | regadenoson | 36000-364 |
| Dr Reddy's Laboratories Inc | regadenoson | 43598-616 |
| >Company | >Ingredient | >NDC |
regadenoson drug variants not containing EDETATE DISODIUM
| Company | Ingredient | NDC |
|---|---|---|
| >Company | >Ingredient | >NDC |
Excipient focus: PROPYLENE GLYCOL
regadenoson drug variants containing PROPYLENE GLYCOL
| Company | Ingredient | NDC |
|---|---|---|
| Hospira Inc | regadenoson | 0409-1401 |
| Hikma Pharmaceuticals USA Inc | regadenoson | 0641-6253 |
| Baxter Healthcare Corporation | regadenoson | 36000-364 |
| Dr Reddy's Laboratories Inc | regadenoson | 43598-616 |
| >Company | >Ingredient | >NDC |
regadenoson drug variants not containing PROPYLENE GLYCOL
| Company | Ingredient | NDC |
|---|---|---|
| >Company | >Ingredient | >NDC |
Excipient focus: SODIUM PHOSPHATE
regadenoson drug variants containing SODIUM PHOSPHATE
| Company | Ingredient | NDC |
|---|---|---|
| Hikma Pharmaceuticals USA Inc | regadenoson | 0641-6253 |
| >Company | >Ingredient | >NDC |
regadenoson drug variants not containing SODIUM PHOSPHATE
| Company | Ingredient | NDC |
|---|---|---|
| Hospira Inc | regadenoson | 0409-1401 |
| Baxter Healthcare Corporation | regadenoson | 36000-364 |
| Dr Reddy's Laboratories Inc | regadenoson | 43598-616 |
| Eugia US LLC | regadenoson | 55150-443 |
| >Company | >Ingredient | >NDC |
Excipient focus: SODIUM PHOSPHATE DIBASIC DIHYDRATE
regadenoson drug variants containing SODIUM PHOSPHATE DIBASIC DIHYDRATE
| Company | Ingredient | NDC |
|---|---|---|
| Hikma Pharmaceuticals USA Inc | regadenoson | 0641-6253 |
| International Medication Systems Limited | regadenoson | 76329-3321 |
| >Company | >Ingredient | >NDC |
regadenoson drug variants not containing SODIUM PHOSPHATE DIBASIC DIHYDRATE
| Company | Ingredient | NDC |
|---|---|---|
| Hospira Inc | regadenoson | 0409-1401 |
| Baxter Healthcare Corporation | regadenoson | 36000-364 |
| Dr Reddy's Laboratories Inc | regadenoson | 43598-616 |
| Eugia US LLC | regadenoson | 55150-443 |
| >Company | >Ingredient | >NDC |
Excipient focus: SODIUM PHOSPHATE, DIBASIC
regadenoson drug variants containing SODIUM PHOSPHATE, DIBASIC
| Company | Ingredient | NDC |
|---|---|---|
| Hikma Pharmaceuticals USA Inc | regadenoson | 0641-6253 |
| >Company | >Ingredient | >NDC |
regadenoson drug variants not containing SODIUM PHOSPHATE, DIBASIC
| Company | Ingredient | NDC |
|---|---|---|
| Hospira Inc | regadenoson | 0409-1401 |
| Baxter Healthcare Corporation | regadenoson | 36000-364 |
| Dr Reddy's Laboratories Inc | regadenoson | 43598-616 |
| Eugia US LLC | regadenoson | 55150-443 |
| >Company | >Ingredient | >NDC |
Excipient focus: SODIUM PHOSPHATE, DIBASIC, ANHYDROUS
regadenoson drug variants containing SODIUM PHOSPHATE, DIBASIC, ANHYDROUS
| Company | Ingredient | NDC |
|---|---|---|
| Hospira Inc | regadenoson | 0409-1401 |
| Meitheal Pharmaceuticals Inc | regadenoson | 71288-201 |
| International Medication Systems Limited | regadenoson | 76329-3321 |
| GE Healthcare | regadenoson anhydrous | 0407-5034 |
| >Company | >Ingredient | >NDC |
regadenoson drug variants not containing SODIUM PHOSPHATE, DIBASIC, ANHYDROUS
| Company | Ingredient | NDC |
|---|---|---|
| Hikma Pharmaceuticals USA Inc | regadenoson | 0641-6253 |
| Baxter Healthcare Corporation | regadenoson | 36000-364 |
| Dr Reddy's Laboratories Inc | regadenoson | 43598-616 |
| Eugia US LLC | regadenoson | 55150-443 |
| >Company | >Ingredient | >NDC |
Excipient focus: SODIUM PHOSPHATE, DIBASIC, DIHYDRATE
regadenoson drug variants containing SODIUM PHOSPHATE, DIBASIC, DIHYDRATE
| Company | Ingredient | NDC |
|---|---|---|
| Baxter Healthcare Corporation | regadenoson | 36000-364 |
| Dr Reddy's Laboratories Inc | regadenoson | 43598-616 |
| Eugia US LLC | regadenoson | 55150-443 |
| Apotex Corp | regadenoson | 60505-6116 |
| >Company | >Ingredient | >NDC |
regadenoson drug variants not containing SODIUM PHOSPHATE, DIBASIC, DIHYDRATE
| Company | Ingredient | NDC |
|---|---|---|
| Hospira Inc | regadenoson | 0409-1401 |
| Hikma Pharmaceuticals USA Inc | regadenoson | 0641-6253 |
| Meitheal Pharmaceuticals Inc | regadenoson | 71288-201 |
| International Medication Systems Limited | regadenoson | 76329-3321 |
| >Company | >Ingredient | >NDC |
Excipient focus: SODIUM PHOSPHATE, MONOBASIC
regadenoson drug variants containing SODIUM PHOSPHATE, MONOBASIC
| Company | Ingredient | NDC |
|---|---|---|
| GE Healthcare | regadenoson anhydrous | 0407-5034 |
| >Company | >Ingredient | >NDC |
regadenoson drug variants not containing SODIUM PHOSPHATE, MONOBASIC
| Company | Ingredient | NDC |
|---|---|---|
| Hospira Inc | regadenoson | 0409-1401 |
| Hikma Pharmaceuticals USA Inc | regadenoson | 0641-6253 |
| Baxter Healthcare Corporation | regadenoson | 36000-364 |
| Dr Reddy's Laboratories Inc | regadenoson | 43598-616 |
| >Company | >Ingredient | >NDC |
Excipient focus: SODIUM PHOSPHATE, MONOBASIC, MONOHYDRATE
regadenoson drug variants containing SODIUM PHOSPHATE, MONOBASIC, MONOHYDRATE
| Company | Ingredient | NDC |
|---|---|---|
| Hospira Inc | regadenoson | 0409-1401 |
| Baxter Healthcare Corporation | regadenoson | 36000-364 |
| Dr Reddy's Laboratories Inc | regadenoson | 43598-616 |
| Eugia US LLC | regadenoson | 55150-443 |
| >Company | >Ingredient | >NDC |
regadenoson drug variants not containing SODIUM PHOSPHATE, MONOBASIC, MONOHYDRATE
| Company | Ingredient | NDC |
|---|---|---|
| Hikma Pharmaceuticals USA Inc | regadenoson | 0641-6253 |
| GE Healthcare | regadenoson anhydrous | 0407-5034 |
| >Company | >Ingredient | >NDC |
Excipient focus: WATER
regadenoson drug variants containing WATER
| Company | Ingredient | NDC |
|---|---|---|
| Hospira Inc | regadenoson | 0409-1401 |
| Hikma Pharmaceuticals USA Inc | regadenoson | 0641-6253 |
| Baxter Healthcare Corporation | regadenoson | 36000-364 |
| Dr Reddy's Laboratories Inc | regadenoson | 43598-616 |
| >Company | >Ingredient | >NDC |
regadenoson drug variants not containing WATER
| Company | Ingredient | NDC |
|---|---|---|
| Mylan Institutional LLC | regadenoson | 67457-994 |
| >Company | >Ingredient | >NDC |
Make Better Decisions: Try a trial or see plans & pricing
Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. We do not provide individual investment advice. This service is not registered with any financial regulatory agency. The information we publish is educational only and based on our opinions plus our models. By using DrugPatentWatch you acknowledge that we do not provide personalized recommendations or advice. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.
